Skip to main content

Table 3 Variables associated with OS according to Cox proportional hazards regression models

From: High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors

Variables

Univariate analysis

Multivariate analysis

HR

95% CI

P

HR

95% CI

P

Sex

Ā Ā 

0.106

Ā Ā Ā 

ā€ƒMale

Reference

Ā Ā Ā Ā Ā 

ā€ƒFemale

NA

NA

Ā Ā Ā Ā 

Age, years

Ā Ā 

0.097

Ā Ā Ā 

ā€ƒā€‰ā‰¤ā€‰60

Reference

Ā Ā Ā Ā Ā 

ā€ƒā€‰>ā€‰60

NA

NA

Ā Ā Ā Ā 

Tumor size, cm

Ā Ā 

0.575

Ā Ā Ā 

ā€ƒā€‰ā‰¤ā€‰2

Reference

Ā Ā Ā Ā Ā 

ā€ƒā€‰>ā€‰2

NA

NA

Ā Ā Ā Ā 

Symptoms

Ā Ā 

0.039

Ā Ā 

0.168

ā€ƒAbsent

Reference

Ā Ā 

Reference

Ā Ā 

ā€ƒPresent

4.768

1.084ā€“20.982

Ā 

NA

NA

Ā 

Tumor location

Ā Ā 

0.424

Ā Ā Ā 

ā€ƒHead/uncinate/neck

Reference

Ā Ā Ā Ā Ā 

ā€ƒBody/tail

NA

NA

Ā Ā Ā Ā 

T-stage

Ā Ā 

0.12

Ā Ā Ā 

ā€ƒT1ā€“2

Reference

Ā Ā Ā Ā Ā 

ā€ƒT3ā€“4

NA

NA

Ā Ā Ā Ā 

Perineural invasion

Ā Ā 

0.019

Ā Ā 

0.430

ā€ƒAbsent

Reference

Ā Ā 

Reference

Ā Ā 

ā€ƒPresent

3.870

1.246ā€“12.023

Ā 

NA

NA

Ā 

LN metastasis

Ā Ā 

<ā€‰0.001

Ā Ā 

0.784

ā€ƒAbsent

Reference

Ā Ā 

Reference

Ā Ā 

ā€ƒPresent

11.916

4.433ā€“32.028

Ā 

NA

NA

Ā 

Distant metastasis

Ā Ā 

<ā€‰0.001

Ā Ā 

0.690

ā€ƒAbsent

Reference

Ā Ā 

Reference

Ā Ā 

ā€ƒPresent

10.102

3.252ā€“31.380

Ā 

NA

NA

Ā 

WHO classification

Ā Ā 

0.010

Ā Ā 

0.540

ā€ƒGrade 1

Reference

Ā Ā 

Reference

Ā Ā 

ā€ƒGrade 2

5.253

1.496ā€“18.443

Ā 

NA

NA

Ā 

AJCC stage

Ā Ā 

<ā€‰0.001

Ā Ā 

<ā€‰0.001

ā€ƒI-II

Reference

Ā Ā 

Reference

Ā Ā 

ā€ƒIII-IV

18.602

5.996ā€“57.709

Ā 

8.646

2.645ā€“28.261

Ā 

EMT markers

Ā Ā 

<ā€‰0.001

Ā Ā 

<ā€‰0.001

ā€ƒOther group

Reference

Ā Ā 

Reference

Ā Ā 

High vimentin and lost E-cadherin expression group

20.888

5.951ā€“73.318

Ā 

10.388

2.794ā€“38.625

Ā 
  1. OS Overall survival, pNETs Pancreatic neuroendocrine tumors, LN Lymph node, AJCC American Joint Committee on Cancer, EMT Epithelial-mesenchymal transition